🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tomas Ø. Jensen

Copenhagen University Hospital

ORCID: 0000-0003-0398-4431

Also affiliated with Centre of Excellence for Health, Immunity and Infections

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial”.

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00215-6
N/A
4.5DataRank · unranked
128 citations

Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits +95 more

Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

The Lancet Microbe(2024)10.1016/s2666-5247(24)00015-6
N/A
0.292DataRank · unranked
6 citations

Thomas A Murray, Greg A Grandits, Mamta K Jain, Birgit Grund, Kathryn Shaw-Saliba +94 more

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad446
N/A
0.241DataRank · unranked
4 citations

Greg Grandits, Mamta K. Jain, Thomas A. Murray, Birgit Grund, Kathryn Shaw‐Saliba +93 more

ACTIV trials: cross-trial lessons learned for master protocol implementation

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.507
N/A
0.229DataRank · unranked
3 citations

Stacey J. Adam, Indira Brar, Lucy Chung, Judith S. Currier, Eric S. Daar +16 more

Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial

Clinical Microbiology and Infection(2025)10.1016/j.cmi.2025.02.002
N/A
0.204DataRank · unranked
2 citations

Gregory Grandits, Lianne Siegel, Nicole Engen, Christina E. Barkauskas, Nnakelu Eriobu +25 more

Impact of Baseline SARS-CoV-2 Load in Plasma and Upper Airways on the Incidence of Acute Extrapulmonary Complications of COVID-19: A Multicentric, Prospective, Cohort Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae469
N/A
0DataRank · unranked
4 citations

Katrina Harper, Shaili Gupta, Sean Liu, Nila J. Dharan, Jason V. Baker +9 more

Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae452
N/A
0DataRank · unranked
0 citations

Eleftherios Mylonakis, Robin Dewar, Barnaby Edward Young, Jacqueline Nordwall, Sanjay Bhagani +37 more

Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort study

International Journal of Infectious Diseases(2025)10.1016/j.ijid.2025.107911
N/A
0DataRank · unranked
0 citations

Shweta Sharma, Anchalee Avihingsanon, Joseph Lutaakome, Indira Brar, William J. Burman +13 more

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

PLoS ONE(2025)10.1371/journal.pone.0325561
N/A
0DataRank · unranked
0 citations

Greg Grandits, Robert C. Hyzy, Hallie C. Prescott, Thomas Barrett, Robin Dewar +24 more